UBS’s Imunon IMNN Stock Holding History

UBS’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$21K	Buy	3 +2	+200%	+$17.4K	﹤0.01%	7953
2014 Q2	$8K	Sell	1 -1	-50%	-$8.93K	﹤0.01%	9090
2014 Q1	$22K	Sell	2 -19	-90%	-$198K	﹤0.01%	7958
2013 Q4	$229K	Buy	21 +6	+40%	+$71.9K	﹤0.01%	5152
2013 Q3	$208K	Sell	15 -9	-38%	-$133K	﹤0.01%	5130
2013 Q2	$299K	Buy	+24	New	+$334K	﹤0.01%	4646

Other funds holding IMNN

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS's IMNN Position: Q3 2014 in Review

UBS increased its Imunon (IMNN) stake by 200% in Q3 2014, buying an estimated $17.4K and bringing the position to 3 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #7953.

UBS first reported a position in IMNN in Q2 2013 and has held it in 6 quarters since. The position peaked at $299K in Q2 2013. 34 funds tracked by Wall St. Rank hold IMNN as of Q3 2014.

UBS held 3 shares of Imunon worth $21K as of Q3 2014.
UBS bought 2 Imunon shares in Q3 2014, an estimated $17.4K.
Imunon made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7953 holding.
UBS first reported a position in Imunon in Q2 2013 and has held it in 6 quarters since.
UBS's Imunon position peaked at $299K in Q2 2013.
34 funds tracked by Wall St. Rank held Imunon as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.